Anavex Life Sciences Corp.
Anavex2-73 for the Treatment of Alzheimer's Disease
Last updated:
Abstract:
Composition and method for treatment of Alzheimer's disease that includes ANAVEX2-73. Method of treatment of Alzheimer's disease using pharmaceutical compositions comprising ANAVEX2-73 according to an intermittent dosage regimen.
Status:
Application
Type:
Utility
Filling date:
27 Sep 2019
Issue date:
23 Jan 2020